
PTCT
Healthcare · Biotechnology · $5.30B market cap
$63.49+0.13 (+0.2%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -4.7% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 29, 2026 | After the close | 0.17 | 0.61 | +258.8% |
| Jul 30, 2026 | After the close | -0.17 | 0.92 | +641.2% |
| May 7, 2026 | After the close | -0.44 | -0.03 | +93.2% |
| Feb 19, 2026 | After the close | -0.40 | -1.80 | -350.0% |
| Nov 4, 2025 | After the close | -1.11 | 0.19 | +117.1% |
| Aug 7, 2025 | After the close | -1.07 | -0.83 | +22.4% |
| May 6, 2025 | After the close | -0.70 | 10.04 | +1534.3% |
| Feb 26, 2025 | After the close | -0.65 | -0.34 | +47.4% |
| Nov 7, 2024 | After the close | -1.66 | -1.36 | +18.1% |
| Aug 8, 2024 | After the close | -0.95 | -1.27 | -33.7% |
| Apr 25, 2024 | After the close | -1.10 | -1.20 | -9.1% |
| Feb 29, 2024 | After the close | 0.50 | -0.24 | -148.0% |
| Oct 26, 2023 | After the close | -1.55 |
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally. The company provides Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder;…
| -1.75 |
| -12.9% |
| Aug 3, 2023 | After the close | -1.71 | -1.58 | +7.6% |
| Apr 27, 2023 | After the close | -1.63 | -1.88 | -15.3% |
| Feb 21, 2023 | After the close | -1.59 | -1.89 | -18.9% |
| Oct 27, 2022 | After the close | -1.26 | -1.53 | -21.4% |
| Aug 4, 2022 | After the close | -1.48 | -2.13 | -43.9% |
| May 3, 2022 | After the close | -1.66 | -1.78 | -7.2% |
| Feb 22, 2022 | After the close | -1.65 | -2.03 | -23.0% |
| Oct 28, 2021 | After the close | -1.89 | -1.89 | 0.0% |
| Jul 29, 2021 | After the close | -1.82 | -1.68 | +7.7% |
| May 4, 2021 | After the close | -1.62 | -1.83 | -13.0% |
| Feb 25, 2021 | After the close | -0.94 | -1.08 | -14.9% |
| Oct 29, 2020 | After the close | -0.45 | -1.03 | -128.9% |
| Aug 5, 2020 | After the close | -1.56 | -1.80 | -15.4% |
| Apr 30, 2020 | After the close | -1.33 | -1.81 | -36.1% |
| Mar 2, 2020 | After the close | -0.71 | -1.37 | -93.0% |
| Oct 29, 2019 | After the close | -0.88 | -0.89 | -1.1% |
| Aug 6, 2019 | After the close | -0.61 | -0.65 | -6.6% |
| May 2, 2019 | After the close | -0.68 | -0.91 | -33.8% |
| Feb 28, 2019 | After the close | -0.32 | -0.58 | -81.3% |
| Nov 5, 2018 | After the close | -0.49 | -1.06 | -116.3% |
| Aug 7, 2018 | After the close | -0.44 | -0.21 | +52.3% |
| May 9, 2018 | After the close | -0.38 | -0.46 | -21.1% |
| Mar 6, 2018 | After the close | -0.14 | 0.03 | +121.4% |